Xyloneural, Injektionslösung

7680427730266 CH-42773 Injektionslösung
Xyloneural, Injektionslösung
Xyloneural, Injektionslösung
Xyloneural, Injektionslösung
1 / 3
google

Article details

Package size
50 x 5 mL
Selling units
250
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
lidocaini hydrochloridum anhydricum
10.0 MG Substance Wirkstoff (Principe actif)
lidocaini hydrochloridum monohydricum
- Substance WIZUS
natrii chloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
3.56 MG Substance HBESI

Authorization holder

Gebro Pharma AG

4410 Liestal

Authorization information

Swissmedic authorization number
42773
Drug name
Xyloneural, Injektionslösung
Galenic form
LSINJ
ATC Code
N01BB02
Authorization status
Revoked/Withdrawn
Dispensing category
B
First authorization
15/01/1981
Authorization expiration date
31/07/2025
IT Number
01.02.2.
Domain
Human medicine
Field of application
Neuraltherapie

Package details

Description (FR)
XYLONEURAL sol inj s cons 50 amp 5 ml
Description (DE)
XYLONEURAL Inj Lös o Kons 50 Amp 5 ml
Market launch
15/01/1981
Market withdrawal
31/07/2025
Narcotic (BTM)
No

Other package sizes (2)

XYLONEURAL sol inj s cons 5 amp 5 ml
5 x 5 mL AMP
GTIN: 7680427730181
View
XYLONEURAL sol inj flac 50 ml
1 x 50 mL DUR
GTIN: 7680427730341
Not in V1
Buy us a coffee Explore the data